Literature DB >> 11354536

Biology of renal cell carcinoma: changing concepts in classification and staging.

A J Pantuck1, A Zisman, A Belldegrun.   

Abstract

Advances in our understanding of the pathogenesis, behavior, and importance of prognostic factors for renal cell carcinoma (RCC) have paved the way for increased sophistication in its classification and staging. In the past, lack of consistent classification and terminology for RCC histology and staging has complicated comparability of clinical studies looking at patient prognosis and response to treatment. In this review, the results of international consensus efforts to achieve uniform classification systems for RCC are outlined and some future directions are considered.

Entities:  

Mesh:

Year:  2001        PMID: 11354536

Source DB:  PubMed          Journal:  Semin Urol Oncol        ISSN: 1081-0943


  8 in total

1.  Best of the 2001 AUA Annual Meeting: Highlights of the 2001 Annual Meeting of the American Urological Association June 2-7, 2001, Anaheim, CA.

Authors: 
Journal:  Rev Urol       Date:  2001

Review 2.  The von Hippel-Lindau gene: turning discovery into therapy.

Authors:  Peter E Clark; Michael S Cookson
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 3.  [Metastatic renal cell carcinoma: therapeutic concepts for non-medicinal treatment].

Authors:  C Wiesner; A Haferkamp
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

4.  Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma.

Authors:  Peter E Clark
Journal:  Biologics       Date:  2010-08-09

5.  Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.

Authors:  Alexander Kutikov; Robert G Uzzo; Aaron Caraway; Carl T Reese; Brian L Egleston; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Yu-Ning Wong; Jay D Raman; Stephen A Boorjian
Journal:  BJU Int       Date:  2009-11-17       Impact factor: 5.588

6.  Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC).

Authors:  Rohan Shahani; Kevin G Kwan; Anil Kapoor
Journal:  Drug Healthc Patient Saf       Date:  2010-06-28

7.  Current status of targeted therapy for advanced renal cell carcinoma.

Authors:  In-Chang Cho; Jinsoo Chung
Journal:  Korean J Urol       Date:  2012-04-18

8.  Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo.

Authors:  W C Duivenvoorden; L K Beatty; S Lhotak; B Hill; I Mak; G Paulin; D Gallino; S Popovic; R C Austin; J H Pinthus
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.